NANOVIRICIDES, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $10.6M | $2.6M |
| FY2020 | — | $21.8M | $13.7M |
| FY2021 | — | $29.9M | $20.5M |
| FY2022 | — | $23.1M | $14.1M |
| FY2023 | — | $14.9M | $8.1M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $10.6M | $2.6M |
| FY2020 | — | $21.8M | $13.7M |
| FY2021 | — | $29.9M | $20.5M |
| FY2022 | — | $23.1M | $14.1M |
| FY2023 | — | $14.9M | $8.1M |